Sustainability Report

The report presents Sun Pharma's FY24 sustainability performance, including an 18.23% reduction in absolute Scope 1 and 2 emissions against its 2020 baseline and renewable energy at 38% of the energy mix. It reports total Scope 3 emissions of 379,788 tCO2e and a 20.96% reduction in water consumption against the same baseline. The company also reports ₹ 1,164 Mn in CSR spending and more than one million beneficiaries.